相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Intratumoral IL-12 delivery empowers CAR-T cell immunotherapy in a pre-clinical model of glioblastoma
Giulia Agliardi et al.
NATURE COMMUNICATIONS (2021)
Increased expression of tryptophan and tyrosine tRNAs elevates stop codon readthrough of reporter systems in human cell lines
Petra Beznoskova et al.
NUCLEIC ACIDS RESEARCH (2021)
Tuning the Antigen Density Requirement for CAR T-cell Activity
Robbie G. Majzner et al.
CANCER DISCOVERY (2020)
Excessive Costimulation Leads to Dysfunction of Adoptively Transferred T Cells
Dinali Wijewarnasuriya et al.
CANCER IMMUNOLOGY RESEARCH (2020)
Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study
Jeremy S. Abramson et al.
LANCET (2020)
One-step generation of modular CAR-T cells with AAV-Cpf1
Xiaoyun Dai et al.
NATURE METHODS (2019)
Intratumor Adoptive Transfer of IL-12 mRNA Transiently Engineered Antitumor CD8+T Cells
Inaki Etxeberria et al.
CANCER CELL (2019)
Safety and efficacy of Tet-regulated IL-12 expression in cancer-specific T cells
Ahdab Alsaieedi et al.
ONCOIMMUNOLOGY (2019)
CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy
Terry J. Fry et al.
NATURE MEDICINE (2018)
'Stop' inprotein synthesis is modulated with exquisite subtlety by an extended RNA translation signal
Warren P. Tate et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2018)
Tumor Antigen and Receptor Densities Regulate Efficacy of a Chimeric Antigen Receptor Targeting Anaplastic Lymphoma Kinase
Alec J. Walker et al.
MOLECULAR THERAPY (2017)
Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection
Justin Eyquem et al.
NATURE (2017)
Therapeutic T cell engineering
Michel Sadelain et al.
NATURE (2017)
Adenovirus-mediated gene delivery: Potential applications for gene and cell-based therapies in the new era of personalized medicine
Cody S. Lee et al.
GENES & DISEASES (2017)
Armored CAR T-cells: utilizing cytokines and pro-inflammatory ligands to enhance CAR T-cell anti-tumour efficacy
Oladapo O. Yeku et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2016)
Immune-related adverse events with immune checkpoint blockade: a comprehensive review
J. M. Michot et al.
EUROPEAN JOURNAL OF CANCER (2016)
Functional Translational Readthrough: A Systems Biology Perspective
Fabian Schueren et al.
PLOS GENETICS (2016)
Tumor-Infiltrating Lymphocytes Genetically Engineered with an Inducible Gene Encoding Interleukin-12 for the Immunotherapy of Metastatic Melanoma
Ling Zhang et al.
CLINICAL CANCER RESEARCH (2015)
Structural basis for stop codon recognition in eukaryotes
Alan Brown et al.
NATURE (2015)
A highly compact epitope-based marker/suicide gene for easier and safer T-cell therapy
Brian Philip et al.
BLOOD (2014)
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
Shannon L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Evidence of efficient stop codon readthrough in four mammalian genes
Gary Loughran et al.
NUCLEIC ACIDS RESEARCH (2014)
Peroxisomal lactate dehydrogenase is generated by translational readthrough in mammals
Fabian Schueren et al.
ELIFE (2014)
B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells
James N. Kochenderfer et al.
BLOOD (2012)
Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning
Hollie J. Pegram et al.
BLOOD (2012)
IL-12 Release by Engineered T Cells Expressing Chimeric Antigen Receptors Can Effectively Muster an Antigen-Independent Macrophage Response on Tumor Cells That Have Shut Down Tumor Antigen Expression
Markus Chmielewski et al.
CANCER RESEARCH (2011)
Evidence of abundant stop codon readthrough in Drosophila and other metazoa
Irwin Jungreis et al.
GENOME RESEARCH (2011)
IL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumors
Sid P. Kerkar et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Improving Adoptive T Cell Therapy by Targeting and Controlling IL-12 Expression to the Tumor Environment
Ling Zhang et al.
MOLECULAR THERAPY (2011)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Genetic control of mammalian T-cell proliferation with synthetic RNA regulatory systems
Yvonne Y. Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Phase II study of interleukin-12 for treatment of plateau phase multiple myeloma (E1A96): A trial of the Eastern Cooperative Oncology Group
Martha Q. Lacy et al.
LEUKEMIA RESEARCH (2009)
Translational efficiency of EMCV IRES in bicistronic vectors is dependent upon IRES sequence and gene location
Yury A. Bochkov et al.
BIOTECHNIQUES (2006)
Identification of stop codon readthrough genes in Saccharomyces cerevisiae
O Namy et al.
NUCLEIC ACIDS RESEARCH (2003)
Predominance of six different hexanucleotide recoding signals 3′ of read-through stop codons
L Harrell et al.
NUCLEIC ACIDS RESEARCH (2002)
Misreading of termination codons in eukaryotes by natural nonsense suppressor tRNAs
H Beier et al.
NUCLEIC ACIDS RESEARCH (2001)
Construction of humanized anti-ganglioside monoclonal antibodies with potent immune effector functions
K Nakamura et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2001)
分享论文
